Pansib, Nena T.

HRN: 01-14-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
CEFTRIAXONE 1G (VIAL)
07/20/2022
07/26/2022
IV
2g
Q24H
Urinary Tract Infection Cystitis Uncomplicated
Waiting Final Action 
07/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/20/2022
07/26/2022
IV
500 Mg
Q8H
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: